What changed in HeartSciences Inc.'s 2023 10-K compared to 2022?

Across the narrative sections we track, HeartSciences Inc. (HSCS) added 0 paragraphs, removed 0, and edited 0 between the 2022 and 2023 10-K filings. The biggest movers are .

Where does this HSCS 10-K diff come from?

The source filings are HeartSciences Inc.'s official 2022 and 2023 Form 10-K annual reports from SEC EDGAR. 10q10k.net parses each filing, aligns paragraphs by section (Item 1, 1A, 1C, 2, 3, 7, 7A), and highlights every added, removed and edited sentence side-by-side.

HeartSciences Inc.HSCSEarnings & Financial Report

Nasdaq · Health Care · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Deep Analysis

Meril Life Sciences is an Indian multinational medical device company, with headquarters in Vapi, Gujarat, India. It was founded in 2006 and is a part of the Bilakhia Group. The company is engaged in the manufacturing of vascular intervention devices, orthopedic implants, robotics, endosurgery, ENT products and in-vitro diagnostics. Meril Life Sciences operates in over 150 countries and has employed 10000 people, as of 2024.

What changed in HeartSciences Inc.'s 10-K — 2022 vs 2023

No meaningful paragraph-level changes detected in the compared sections. Either the two filings are nearly identical or the sections did not parse.

Other HSCS 10-K year-over-year comparisons

HSCS 10-K 2024 vs 2025
HSCS 10-K 2023 vs 2024